Showing results (531-540 of 1,877) with videos related to

Sort By:
Pageof 188
Immunotherapy|August 13, 2021
Clinical course and management of pembrolizumab-associated isolated adrenocorticotrophic hormone deficiency: a new case and literature reviewSeda Hanife Oğuz, Uğur Ünlütürk, Sercan Aksoy, et al.
Immunotherapy|August 25, 2021
Immune checkpoint inhibitors use and effects on prognosis of COVID-19 infection: a systematic review and meta-analysisWenwei Qian, Ying Ye, Lugen Zuo, et al.
Immunotherapy|November 17, 2021
Immunotherapy and Sonpavde score validation in advanced upper tract urothelial carcinoma: a retrospective study by the Italian Network for Research in Urologic-Oncology (Meet-URO group)Melissa Bersanelli, Giulia Mazzaschi, Patrizia Giannatempo, et al.
Immunotherapy|November 17, 2021
Immunomodulation with β-glucan from Pleurotus ostreatus in patients with endocrine-dependent breast cancerJan Spacek, Michal Vocka, Eva Zavadova, et al.
Immunotherapy|December 21, 2021
Infection rates and tolerability of three different immunoglobulin administration modalities in patients with primary immunodeficiency diseasesRichard L Wasserman, Sudhir Gupta, Mark Stein, et al.
Immunotherapy|December 1, 2021
How bilastine is used to treat allergic rhinitis and urticaria in childrenPablo Rodríguez Del Río, Fernando Rodríguez Fernández, Esther Ballester Asensio, et al.
Immunotherapy|December 6, 2021
An update on the adalimumab biosimilar landscape following the approval of the first high-concentration biosimilarEnrico Fusaro, Patrick Durez, Johannes Wohlrab, et al.
Immunotherapy|December 7, 2021
Vanishing bile duct syndrome following pembrolizumab infusion: case report and review of the literatureMaria Gemelli, Marco Carbone, Maria I Abbate, et al.
Immunotherapy|November 23, 2021
Severe pseudomembranous keratoconjunctivitis with deterioration of eyesight induced by immune checkpoint inhibitorsTetsuya Urasaki, Masatoshi Nishizawa, Atsushi Yoshida, et al.
Immunotherapy|January 5, 2022
Peripheral blood eosinophil count is associated with response to chemoimmunotherapy in metastatic triple-negative breast cancerHazem Ghebeh, Mahmoud A Elshenawy, Adher D AlSayed, et al.
Pageof 188